Anhui Huaheng Biotechnology Co., Ltd. (SHA:688639)
China · Delayed Price · Currency is CNY 17.00
-0.20 (-1.16%)
Aug 4, 2026, 3:00 PM CST
SHA:688639 Market Cap
SHA:688639 has a market cap or net worth of 4.24 billion as of August 4, 2026. Its market cap has decreased by -51.66% in one year.
Market Cap
4.24B
Enterprise Value
6.14B
Revenue
2.95B
Ranking
n/a
PE Ratio
34.14
Stock Price
17.00
ChartMarket Cap Chart
Since April 22, 2021, SHA:688639's market cap has increased from 3.81B to 4.24B, an increase of 11.37%. That is a compound annual growth rate of 2.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.24B | -47.82% |
| Dec 31, 2025 | 8.13B | 10.70% |
| Dec 31, 2024 | 7.34B | -62.99% |
| Dec 29, 2023 | 19.83B | 17.86% |
| Dec 30, 2022 | 16.83B | 20.56% |
| Dec 31, 2021 | 13.96B | 266.67% |
| Apr 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Shouyao Holdings (Beijing) Co., LTD. | 4.73B |
| Beijing Konruns Pharmaceutical | 4.70B |
| Shenzhen Weiguang Biological Products | 4.58B |
| R&G PharmaStudies | 4.54B |
| ChemPartner PharmaTech | 4.54B |
| Xiangxue Pharmaceutical | 4.46B |
| PharmaResources (Shanghai) | 4.38B |
| Wuhan Hvsen Biotechnology | 4.21B |